In the complex infectious disease case of SARS-CoV-2, mediKanren unveiled the pathway of androgen-induced expression of TMPRSS2, which ultimately led to a clinical trial of androgen deprivation therapy for decreasing disease severity. This evidence concerns the gene TMPRSS2 and infectious disease.